Tuesday 27 September 2016

Edelman Australia hires Will Collie to lead new Healthcare portfolio

Edelman Australia has today announced the appointment of Will Collie as Director of its Healthcare practice based in Sydney.

Under Will’s lead, Edelman’s health portfolio will broaden its focus from traditional media relations and issues management to four additional areas: patient engagement, stakeholder planning, social media health strategy, and digital pharmacovigilance.

Will has over ten years experience spanning the health and wellness and consumer marketing sectors and most recently was Senior Manager External Affairs for global pharmaceutical company Sanofi, where his responsibilities included the management of all proactive and reactive public relations, issues management and media activity for the Australian and New Zealand affiliate.

Previously within Australia, Will has held roles at Weber Shandwick and PPR and joins Edelman having been a member of the Medicines Australia Media Working Group for the last three years.

Will has worked in various sectors of health including diabetes, oncology, multiple sclerosis, renal and cardiovascular disease and was awarded Best PR Campaign in 2010 and 2011 for the pharmaceutical industry’s PRIME Awards for his work in vaccines and smoking cessation.

Will presents regularly at industry conferences and in 2011 delivered insights at the inaugural Digital Pharma Conference and the Australian Research Collaboration Service (ARCS) Conference, on the role of public relations practitioners in delivering social media strategy to the Australian pharmaceutical industry.

Will’s return to agency will see him work across a portfolio of current Edelman clients including: Sanofi Consumer Healthcare, Sanofi Pasteur, the Baker IDI, and Reckitt Benckiser while actively growing the division’s footprint. He will be reporting directly into Michelle Hutton, CEO of Edelman Australia.

“We’re delighted to welcome Will to Edelman Australia,” said Michelle Hutton. “We have long been recognised as a leader in healthcare communication here and internationally and under Will’s direction we will continue to refresh and evolve our offer.”